Literature DB >> 24720265

The effect of three desensitizing agents on dentin hypersensitivity: a randomized, split-mouth clinical trial.

C R G Torres, T M Silva, B M Fonseca, A L L S Sales, P Holleben, R Di Nicolo, A B Borges.   

Abstract

The aim of this study was to evaluate the efficacy of three desensitizing agents to provide relief to dentin hypersensitivity after one session in a four-week follow-up. Forty selected patients participated in a double-blind study following a split-mouth model. One application of the desensitizing agents (A, Admira Protect [Voco]; B, Bifluorid 12 [Voco]; and C, Colgate Pro-Relief in office [Colgate Palmolive]) was performed in three different quadrants for each patient. Each tooth was evaluated by tactile and evaporative stimuli, and the sensitivity response was measured using the Visual Analogue Scale. Evaluations were performed at baseline, immediately after treatment, and after one, two, three, and four weeks. The application of Kruskal-Wallis and Dunn multiple comparisons tests (5%) for both tactile and evaporative stimuli showed that all agents presented a significant desensitizing effect. In groups A and B this relief was maintained for four and three weeks, respectively, as measured by tactile stimulus and for four weeks with evaporative stimulus. The desensitizing effect for group C was maintained for two weeks for both tactile and evaporative stimuli. It is concluded that all desensitizing agents tested were effective in reducing sensitivity compared to baseline values. One application of Admira Protect and Bifluorid 12 presented a longer-lasting desensitizing effect than did Colgate Pro-Relief (applied in the office) on both tactile and evaporative stimuli.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24720265     DOI: 10.2341/13-057

Source DB:  PubMed          Journal:  Oper Dent        ISSN: 0361-7734            Impact factor:   2.440


  7 in total

1.  A comparative evaluation of propolis and light-cured ormocer-based desensitizer in reducing dentin hypersensitivity.

Authors:  Snigdha Maity; Vidya Priyadharshini; Suman Basavaraju
Journal:  J Indian Soc Periodontol       Date:  2020-09-01

2.  Effect of two desensitizing agents on dentin hypersensitivity: A randomized split-mouth clinical trial.

Authors:  Angambakkam Rajasekaran PradeepKumar; Venkatnagaraj Viswanath; Kamna Singh; Kuzhanchinathan Manigandan; HaseenaBegum Iqbal; Anil Kishen
Journal:  J Conserv Dent       Date:  2020-08-20

3.  Comparative evaluation of the efficacy of the desensitizing and remineralizing agent in the reduction of dentin hypersensitivity after orthodontic debonding - a randomized clinical trial.

Authors:  Sasipriya Vatturu; Vivek Reddy Ganugapanta; Naga Ravi Teja; Gowri Sankar Singaraju; Prasad Mandava; Js Yamini Priyanka
Journal:  Med Pharm Rep       Date:  2021-04-29

4.  Comparative Evaluation of the Effects of Diode Laser and Desensitizing Agents on the Treatment of Dentin Hypersensitivity: a Clinical Study.

Authors:  Mirjana Gojkov-Vukelic; Sanja Hadzic; Indira Mujic Jahic; Enes Pasic; Arma Muharemovic
Journal:  Acta Inform Med       Date:  2021-06

5.  The Retention Effect of Resin-Based Desensitizing Agents on Hypersensitivity-A Randomized Controlled Trial.

Authors:  Manami Tadano; Tomoaki Nakamura; Seira Hoshikawa; Ryoko Hino; Yuriko Maruya; Aya Yamada; Satoshi Fukumoto; Kan Saito
Journal:  Materials (Basel)       Date:  2022-07-26       Impact factor: 3.748

6.  Efficacy of nano-carbonate apatite dentifrice in relief from dentine hypersensitivity following non-surgical periodontal therapy: a randomized controlled trial.

Authors:  Pei-Hui Ding; Anna Dai; Hua-Jiao Hu; Jia-Ping Huang; Jia-Mei Liu; Li-Li Chen
Journal:  BMC Oral Health       Date:  2020-06-12       Impact factor: 2.757

7.  Effectiveness of sodium fluoride varnish and/or diode laser in decreasing post-bleaching hypersensitivity: A comparative study.

Authors:  Ghidaa Yahya; Anwar AlAlwi; Farah Shurayji; Waad Baroom; Mona Rajeh; Nada AbdelAleem
Journal:  Saudi Dent J       Date:  2021-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.